KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Long-Term Debt Issuances (2019 - 2020)

Historic Long-Term Debt Issuances for Inovio Pharmaceuticals (INO) over the last 2 years, with Q2 2020 value amounting to $171620.0.

  • Inovio Pharmaceuticals' Long-Term Debt Issuances changed N/A to $171620.0 in Q2 2020 from the same period last year, while for Sep 2021 it was $171620.0, marking a year-over-year decrease of 9590.33%. This contributed to the annual value of $171620.0 for FY2020, which is 9982.39% down from last year.
  • According to the latest figures from Q2 2020, Inovio Pharmaceuticals' Long-Term Debt Issuances is $171620.0.
  • Over the past 5 years, Inovio Pharmaceuticals' Long-Term Debt Issuances peaked at $75.7 million during Q1 2019, and registered a low of $171620.0 during Q2 2020.